Format
Sort by

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 130

1.

Mitragynine concentrations in two fatalities.

Domingo O, Roider G, Stöver A, Graw M, Musshoff F, Sachs H, Bicker W.

Forensic Sci Int. 2017 Feb;271:e1-e7. doi: 10.1016/j.forsciint.2016.12.020.

PMID:
28089300
2.

<i>Mitragyna speciosa</i> Leaf Extract Exhibits Antipsychotic-Like Effect with the Potential to Alleviate Positive and Negative Symptoms of Psychosis in Mice.

Vijeepallam K, Pandy V, Kunasegaran T, Murugan DD, Naidu M.

Front Pharmacol. 2016 Dec 6;7:464. doi: 10.3389/fphar.2016.00464.

3.

"Evaluation of ion mobility spectrometry for the detection of mitragynine in kratom products".

Fuenffinger N, Ritchie M, Ruth A, Gryniewicz-Ruzicka C.

J Pharm Biomed Anal. 2017 Feb 5;134:282-286. doi: 10.1016/j.jpba.2016.11.055.

PMID:
27951469
4.

Update on the Pharmacology and Legal Status of Kratom.

Prozialeck WC.

J Am Osteopath Assoc. 2016 Dec 1;116(12):802-809. doi: 10.7556/jaoa.2016.156.

PMID:
27893147
6.

Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine.

Lydecker AG, Sharma A, McCurdy CR, Avery BA, Babu KM, Boyer EW.

J Med Toxicol. 2016 Dec;12(4):341-349.

PMID:
27752985
8.

Mitragynine/Corynantheidine Pseudoindoxyls As Opioid Analgesics with Mu Agonism and Delta Antagonism, Which Do Not Recruit β-Arrestin-2.

Váradi A, Marrone GF, Palmer TC, Narayan A, Szabó MR, Le Rouzic V, Grinnell SG, Subrath JJ, Warner E, Kalra S, Hunkele A, Pagirsky J, Eans SO, Medina JM, Xu J, Pan YX, Borics A, Pasternak GW, McLaughlin JP, Majumdar S.

J Med Chem. 2016 Sep 22;59(18):8381-97. doi: 10.1021/acs.jmedchem.6b00748.

PMID:
27556704
9.

Notes from the Field: Kratom (Mitragyna speciosa) Exposures Reported to Poison Centers - United States, 2010-2015.

Anwar M, Law R, Schier J.

MMWR Morb Mortal Wkly Rep. 2016 Jul 29;65(29):748-9. doi: 10.15585/mmwr.mm6529a4.

10.

Mitragynine and its potential blocking effects on specific cardiac potassium channels.

Tay YL, Teah YF, Chong YM, Jamil MF, Kollert S, Adenan MI, Wahab HA, Döring F, Wischmeyer E, Tan ML.

Toxicol Appl Pharmacol. 2016 Aug 15;305:22-39. doi: 10.1016/j.taap.2016.05.022.

PMID:
27260674
11.

Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators.

Kruegel AC, Gassaway MM, Kapoor A, Váradi A, Majumdar S, Filizola M, Javitch JA, Sames D.

J Am Chem Soc. 2016 Jun 1;138(21):6754-64. doi: 10.1021/jacs.6b00360.

12.

Neurobiology of Kratom and its main alkaloid mitragynine.

Suhaimi FW, Yusoff NH, Hassan R, Mansor SM, Navaratnam V, Müller CP, Hassan Z.

Brain Res Bull. 2016 Sep;126(Pt 1):29-40. doi: 10.1016/j.brainresbull.2016.03.015. Review.

PMID:
27018165
13.

Factor Analytical Investigation of Krathom (Mitragyna speciosa Korth.) Withdrawal Syndrome in Thailand.

Saingam D, Assanangkornchai S, Geater AF, Lerkiatbundit S.

J Psychoactive Drugs. 2016 Apr-Jun;48(2):76-85. doi: 10.1080/02791072.2016.1156791.

PMID:
27015537
15.

Chronic mitragynine (kratom) enhances punishment resistance in natural reward seeking and impairs place learning in mice.

Ismail NI, Jayabalan N, Mansor SM, Müller CP, Muzaimi M.

Addict Biol. 2016 Mar 17. doi: 10.1111/adb.12385. [Epub ahead of print]

PMID:
26990882
16.

Comparative effects of Mitragyna speciosa extract, mitragynine, and opioid agonists on thermal nociception in rats.

Carpenter JM, Criddle CA, Craig HK, Ali Z, Zhang Z, Khan IA, Sufka KJ.

Fitoterapia. 2016 Mar;109:87-90. doi: 10.1016/j.fitote.2015.12.001.

PMID:
26688378
17.

Herbal Supplements and Hepatotoxicity: A Short Review.

Haslan H, Suhaimi FH, Das S.

Nat Prod Commun. 2015 Oct;10(10):1779-84. Review.

PMID:
26669124
18.

APPLICATION OF CHEMOMETRICS FOR IDENTIFICATION OF PSYCHOACTIVE PLANTS.

Kowalczuk AP, Łozak A, Kiljan M, Mętrak K, Zjawiony JK.

Acta Pol Pharm. 2015 May-Jun;72(3):517-25.

19.

Following "the Roots" of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries.

Cinosi E, Martinotti G, Simonato P, Singh D, Demetrovics Z, Roman-Urrestarazu A, Bersani FS, Vicknasingam B, Piazzon G, Li JH, Yu WJ, Kapitány-Fövény M, Farkas J, Di Giannantonio M, Corazza O.

Biomed Res Int. 2015;2015:968786. doi: 10.1155/2015/968786. Review.

20.

Experiences of Kratom Users: A Qualitative Analysis.

Swogger MT, Hart E, Erowid F, Erowid E, Trabold N, Yee K, Parkhurst KA, Priddy BM, Walsh Z.

J Psychoactive Drugs. 2015 Nov-Dec;47(5):360-7. doi: 10.1080/02791072.2015.1096434.

PMID:
26595229
Items per page

Supplemental Content

Loading ...
Support Center